| dc.contributor.author |
Mahesh, R. |
|
| dc.date.accessioned |
2023-11-23T06:42:49Z |
|
| dc.date.available |
2023-11-23T06:42:49Z |
|
| dc.date.issued |
2017-08 |
|
| dc.identifier.uri |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754936/ |
|
| dc.identifier.uri |
http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13234 |
|
| dc.description.abstract |
Obesity is an important risk factor for depression as more than half of the obese population is susceptible for depression at double rate. Our earlier studies reported the antidepressant potential of 5-HT3 receptor antagonist, ondansetron (OND) in depression associated obesity using behavioral tasks. The present research work is aimed to evaluate the effect of OND on depression associated with obesity with special emphasis on biochemical and molecular mechanisms such as hippocampal brain-derived neurotrophic factor (BDNF), cyclic adenosine monophosphate (cAMP), 5-hydroxytryptamine (5-HT), hippocampal histological examination and immunohistochemical expression of p53 proteins. |
en_US |
| dc.language.iso |
en |
en_US |
| dc.publisher |
IJP |
en_US |
| dc.subject |
Pharmacy |
en_US |
| dc.subject |
5-HT3 receptor antagonist |
en_US |
| dc.subject |
Comorbid depression |
en_US |
| dc.subject |
Serotonergic neurotransmission |
en_US |
| dc.title |
Ondansetron ameliorates depression associated with obesity in high-fat diet fed experimental mice: An investigation-based on the behavioral, biochemical, and molecular approach |
en_US |
| dc.type |
Article |
en_US |